Research has found that, in diabetic models, EGCG indirectly inhibits the stability of TLR4 mRNA by promoting Fat Mass and Obesity-Associated Protein degradation, thereby reducing TLR4 protein expression [39]. This evidence concerns the gene TLR4 and obesity disorder.